EurekaMag.com logo
+ Site Statistics
References:
53,517,315
Abstracts:
29,339,501
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Long-term follow-up after acute myocardial infarction in patients randomized to treatment with intravenous magnesium or intravenous propranolol in the acute phase



Long-term follow-up after acute myocardial infarction in patients randomized to treatment with intravenous magnesium or intravenous propranolol in the acute phase



Magnesium Research 7(3-4): 273-276



Ninety-five patients with acute myocardial infarction were followed up for 6 months to 3 years (mean 25.4 months) in a preliminary study to compare the effects of intravenous magnesium (49 patients) with that of intravenous propranolol (44 patients) given immediately after admission to the intensive care unit. There were four cardiac deaths in the propranolol group and no deaths in the magnesium group (P < 0.046) and 27 per cent of patients who received propranolol subsequently developed cardiac failure as opposed to 12 per cent of those who had received magnesium (P < 0.04). Intravenous magnesium given in the early stages of myocardial infarction reduces the subsequent cardiac death rate possibly by reducing infarct size.

(PDF 0-2 workdays service: $29.90)

Accession: 008970567

Download citation: RISBibTeXText

PMID: 7786690



Related references

A prospective randomized trial of intravenous magnesium versus intravenous propranolol in acute myocardial infarction. Magnesium Research 7(3-4): 267-271, 1994

Long-term outcome after intravenous magnesium sulphate in suspected acute myocardial infarction: the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet 343(8901): 816-819, 1994

Long-term outcome after intravenous magnesium sulphate in suspected acute myocardial infarction: The second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2): Woods KL, Fletcher S Lancet 343:816819 Apr 1994. Annals of Emergency Medicine 24(3): 545-0, 1994

Long-term outcome of intravenous magnesium therapy in thrombolysis-ineligible acute myocardial infarction patients. Cardiology 99(4): 205-210, 2003

Effects of intravenous magnesium sulphate in suspected acute myocardial infarction on acute arrhythmias and long-term outcome. International Journal Of Cardiology. 49(2): 143-151, 1995

Long-term outcome in thrombolysis-ineligible acute myocardial infarction patients treated with intravenous magnesium sulfate. Circulation 104(17 Supplement): II 744-II 745, October 23, 2001

Long-term follow-up of acute myocardial infarction after early intravenous streptokinase. Harefuah 116(1): 6-11, 1989

Effect of 48-h intravenous trimetazidine on short- and long-term outcomes of patients with acute myocardial infarction, with and without thrombolytic therapy; A double-blind, placebo-controlled, randomized trial. The EMIP-FR Group. European Myocardial Infarction Project--Free Radicals. European Heart Journal 21(18): 1537-1546, 2000

Short- and long-term effects of early fosinopril administration in patients with acute anterior myocardial infarction undergoing intravenous thrombolysis: Results from the Fosinopril in Acute Myocardial Infarction Study. American Heart Journal 136(2): 213-225, 1998

Treatment of patients with acute myocardial infarction with intravenous magnesium. Magnesium and Trace Elements 9(4): 177-185, 1990

Favorable long-term results of primary percutaneous transluminal coronary angioplasty in acute myocardial infarction compared to intravenous streptokinase treatment; a randomized study. Nederlands Tijdschrift Voor Geneeskunde 139(49): 2564-2567, 1995

Acute ST segment deviation is a predictor of long-term prognosis in patients treated with intravenous thrombolytic therapy for acute myocardial infarction. European Heart Journal 14(ABSTR SUPPL ): 398, 1993

Incidence and consequence of major bleeding in primary percutaneous intervention for ST-elevation myocardial infarction in the era of radial access: an analysis of the international randomized Acute myocardial infarction Treated with primary angioplasty and intravenous enoxaparin Or unfractionated heparin to Lower ischemic and bleeding events at short- and Long-term follow-up trial. American Heart Journal 170(4): 778-786, 2015

Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet 339(8809): 1553-1558, 1992

The effect of intravenous magnesium sulphate on mortality and morbidity of suspected acute myocardial infarction Results of the Second Leicester Intravenous Magnesium Intervention Trial. Circulation 86(4 SUPPL 1): I641, 1992